Generic Blood Pressure Medication Cleared by FDA

 

March 23, 2010

The FDA granted approval for diltiazem hydrochloride extended-release tablets to treat hypertension, which is the generic equivalent to Biovail Laboratories International SRL's Cardizem LA product.

Watson Pharmaceuticals Inc. will produce the generic drug and plans for its immediate release. For the 12-months ending Dec. 31, 2009, Cardizem LA had total U.S. sales of approximately $94.1 million, according to IMS Health.

The generic drug was cleared in March 2010.

For more information: www.watson.com